183 related articles for article (PubMed ID: 19862340)
1. Study of the expression of CD30 in pterygia compared to healthy conjunctivas.
Garfias Y; Bautista-De Lucio VM; García C; Nava A; Villalvazo L; Jiménez-Martínez MC
Mol Vis; 2009 Oct; 15():2068-73. PubMed ID: 19862340
[TBL] [Abstract][Full Text] [Related]
2. Expression of cell proliferation and apoptosis biomarkers in pterygia and normal conjunctiva.
Liang K; Jiang Z; Ding BQ; Cheng P; Huang DK; Tao LM
Mol Vis; 2011; 17():1687-93. PubMed ID: 21738398
[TBL] [Abstract][Full Text] [Related]
3. Expression of p27(KIP1) and cyclin D1, and cell proliferation in human pterygium.
Kase S; Takahashi S; Sato I; Nakanishi K; Yoshida K; Ohno S
Br J Ophthalmol; 2007 Jul; 91(7):958-61. PubMed ID: 17179165
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of erythropoietin receptor in human pterygial tissues.
Kase S; Osaki M; Jin XH; Ohgami K; Yoshida K; Saito W; Takahashi S; Nakanishi K; Ito H; Ohno S
Int J Mol Med; 2007 Nov; 20(5):699-702. PubMed ID: 17912463
[TBL] [Abstract][Full Text] [Related]
5. Ηypoxia-inducible factor-1α, von Hippel-Lindau protein, and heat shock protein expression in ophthalmic pterygium and normal conjunctiva.
Pagoulatos D; Pharmakakis N; Lakoumentas J; Assimakopoulou M
Mol Vis; 2014; 20():441-57. PubMed ID: 24715760
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of vascular endothelial growth factor implies the limbal origin of pterygia.
Gebhardt M; Mentlein R; Schaudig U; Pufe T; Recker K; Nölle B; Al-Samir K; Geerling G; Paulsen FP
Ophthalmology; 2005 Jun; 112(6):1023-30. PubMed ID: 15885787
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of c-Myc in pterygium and cultured pterygial cells.
Cui D; Pan Z; Zhang S; Zheng J; Huang Q; Wu K
Clin Exp Ophthalmol; 2011 Nov; 39(8):784-92. PubMed ID: 22050566
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical detection of Hsp90 and Ki-67 in pterygium.
Sebastiá R; Ventura MP; Solari HP; Antecka E; Orellana ME; Burnier MN
Diagn Pathol; 2013 Feb; 8():32. PubMed ID: 23432803
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical HLA-DR antigen expression with lymphocyte subsets and proliferative activity in pterygium.
Tsironi S; Ioachim E; Machera M; Aspiotis M; Agnantis N; Psillas K
In Vivo; 2002; 16(5):299-306. PubMed ID: 12494867
[TBL] [Abstract][Full Text] [Related]
10. Calcium-binding S100 protein expression in pterygium.
Riau AK; Wong TT; Beuerman RW; Tong L
Mol Vis; 2009; 15():335-42. PubMed ID: 19223989
[TBL] [Abstract][Full Text] [Related]
11. Distribution of vimentin-expressing cells in pterygium: an immunocytochemical study of impression cytology specimens.
Chen YT; Tseng SH; Tsai YY; Huang FC; Tseng SY
Cornea; 2009 Jun; 28(5):547-52. PubMed ID: 19421041
[TBL] [Abstract][Full Text] [Related]
12. DNA damage in human pterygium: one-shot multiple targets.
Cimpean AM; Sava MP; Raica M
Mol Vis; 2013; 19():348-56. PubMed ID: 23401662
[TBL] [Abstract][Full Text] [Related]
13. Tissue factor expression in human pterygium.
Ando R; Kase S; Ohashi T; Dong Z; Fukuhara J; Kanda A; Murata M; Noda K; Kitaichi N; Ishida S
Mol Vis; 2011 Jan; 17():63-9. PubMed ID: 21245964
[TBL] [Abstract][Full Text] [Related]
14. Immunolocalization of cannabinoid receptor type 1 and CB2 cannabinoid receptors, and transient receptor potential vanilloid channels in pterygium.
Assimakopoulou M; Pagoulatos D; Nterma P; Pharmakakis N
Mol Med Rep; 2017 Oct; 16(4):5285-5293. PubMed ID: 28849159
[TBL] [Abstract][Full Text] [Related]
15. Expression of p53 and Ki-67 proteins in patients with increasing severity and duration of pterygium.
Mahesh M; Mittal SK; Kishore S; Singh A; Gupta N; Rana R
Indian J Ophthalmol; 2021 Apr; 69(4):847-850. PubMed ID: 33727444
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical profile of VEGF, TGF-β and PGE₂ in human pterygium and normal conjunctiva: experimental study and review of the literature.
Bianchi E; Scarinci F; Grande C; Plateroti R; Plateroti P; Plateroti AM; Fumagalli L; Capozzi P; Feher J; Artico M
Int J Immunopathol Pharmacol; 2012; 25(3):607-15. PubMed ID: 23058011
[TBL] [Abstract][Full Text] [Related]
17. Proliferative activity and p53 expression in primary and recurrent pterygia.
Chowers I; Pe'er J; Zamir E; Livni N; Ilsar M; Frucht-Pery J
Ophthalmology; 2001 May; 108(5):985-8. PubMed ID: 11320032
[TBL] [Abstract][Full Text] [Related]
18. Immunophenotypic characterization of telocyte-like cells in pterygium.
Maxia C; Murtas D; Isola M; Tamma R; Zucca I; Piras F; Ribatti D; Diana A; Perra MT
Mol Vis; 2018; 24():853-866. PubMed ID: 30713424
[TBL] [Abstract][Full Text] [Related]
19. The role of cyclin D1, BCL-2, p53 and Ki-67 in epithelial cells in the etiopathogenesis of pterygium.
Süren E; Nergiz D; Bilgin B; Çoban DT; Akgündüz Z; Sadullahoğlu C; Süren D
Indian J Pathol Microbiol; 2021; 64(2):238-242. PubMed ID: 33851614
[TBL] [Abstract][Full Text] [Related]
20. Proliferative and migratory aptitude in pterygium.
Bai H; Teng Y; Wong L; Jhanji V; Pang CP; Yam GH
Histochem Cell Biol; 2010 Nov; 134(5):527-35. PubMed ID: 20938674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]